LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 63

Search options

  1. Article ; Online: Application of a Novel CL7/Im7 Affinity System in Purification of Complex and Pharmaceutical Proteins.

    Chow, Louise T / Vassylyev, Dmitry G

    Methods in molecular biology (Clifton, N.J.)

    2022  Volume 2466, Page(s) 61–82

    Abstract: We have developed the CL7/Im7 protein purification system to achieve high-yield, high-purity and high-activity (HHH) products in one step. The system is based on the natural ultrahigh-affinity complex between the two small proteins encoded by ... ...

    Abstract We have developed the CL7/Im7 protein purification system to achieve high-yield, high-purity and high-activity (HHH) products in one step. The system is based on the natural ultrahigh-affinity complex between the two small proteins encoded by colicinogenic plasmids carried by certain E. coli strains, the DNAse domain of colicin E7 (CE7; MW ~ 15 kDa) and its natural endogenous inhibitor, the immunity protein 7 (Im7; MW ~ 10 kDa). CL7 is an engineered variant of CE7, in which the toxic DNA-binding and catalytic activities have been eliminated while retaining the high affinity to Im7. CL7 is used as a protein tag, while Im7 is covalently attached to agarose beads. To make the CL7/Im7 technique easy to use, we have designed a set of the E. coli expression vectors for fusion of a target protein to the protease-cleavable CL7-tag either at the N- or the C-terminus, and also have the options of the dual (CL7/His8) tag. A subset of vectors is dedicated for cloning membrane and multisubunit proteins. The CL7/Im7 system has several notable advatantages over other available affinity purification techniques. First, high concentrations of the small Im7 protein are coupled to the beads resulting in the high column capacities (up to 60 mg/mL). Second, an exceptional stability of Im7 allows for multiple (100+) regeneration cycles with no loss of binding capacities. Third, the CL7-tag improves protein expression levels, solubility and, in some cases, assists folding of the target proteins. Fourth, the on-column proteolytic elution produces purified proteins with few or no extra amino acid residues. Finally, the CL7/Im7 affinity is largely insensitive to high salt concentrations. For many target proteins, loading the bacterial lysates on the Im7 column in high salt is a key to high purity. Altogether, these properties of the CL7/Im7 system allow for a one-step HHH purification of most challenging, biologically and clinically significant proteins.
    MeSH term(s) Chromatography, Affinity/methods ; Colicins/chemistry ; Colicins/genetics ; Colicins/metabolism ; Escherichia coli/metabolism ; Escherichia coli Proteins/metabolism ; Peptide Hydrolases/metabolism ; Pharmaceutical Preparations/metabolism ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism
    Chemical Substances Colicins ; Escherichia coli Proteins ; Pharmaceutical Preparations ; Recombinant Fusion Proteins ; Peptide Hydrolases (EC 3.4.-)
    Language English
    Publishing date 2022-01-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-2176-9_5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers.

    Chow, Louise T

    Virologica Sinica

    2015  Volume 30, Issue 2, Page(s) 92–100

    Abstract: The prevalent human papillomaviruses (HPVs) infect either cutaneous or mucosal epithelium. Active Infections lead to epithelial hyperprolifeation and are usually cleared in healthy individuals within a year. Persistent infections in the anogenital tracts ...

    Abstract The prevalent human papillomaviruses (HPVs) infect either cutaneous or mucosal epithelium. Active Infections lead to epithelial hyperprolifeation and are usually cleared in healthy individuals within a year. Persistent infections in the anogenital tracts by certain high-risk genotypes such as HPV-16, HPV-18 and closely related types, can progress to high grade dysplasias and carcinomas in women and men, including cervical, vulva, penile and anal cancers. A significant fraction of the head and neck cancers are also caused by HPV-16. The viral oncogenes responsible for neoplastic conversion are E6 and E7 that disrupt the pathways controlled by the two major tumor suppressor genes, p53 and members of pRB family. Because HPV cannot be propagated in conventional submerged monolayer cell cultures, organotypic epithelial raft cultures that generate a stratified and differentiated epithelium have been used to study the viral life cycle. This article describes several systems to examine aspects of the viral productive phase, along with the advantages and limitations. Animal model systems of HPV carcinogenesis are also briefly described.
    MeSH term(s) Animals ; Disease Models, Animal ; Host-Pathogen Interactions ; Humans ; Neoplasms/virology ; Organ Culture Techniques ; Papillomaviridae/physiology
    Language English
    Publishing date 2015-04-23
    Publishing country China
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1011219-4
    ISSN 1995-820X ; 1000-3223 ; 1003-5125
    ISSN (online) 1995-820X
    ISSN 1000-3223 ; 1003-5125
    DOI 10.1007/s12250-015-3600-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers

    Chow, Louise T

    Virologica Sinica. 2015 Apr., v. 30, no. 2

    2015  

    Abstract: The prevalent human papillomaviruses (HPVs) infect either cutaneous or mucosal epithelium. Active Infections lead to epithelial hyperprolifeation and are usually cleared in healthy individuals within a year. Persistent infections in the anogenital tracts ...

    Abstract The prevalent human papillomaviruses (HPVs) infect either cutaneous or mucosal epithelium. Active Infections lead to epithelial hyperprolifeation and are usually cleared in healthy individuals within a year. Persistent infections in the anogenital tracts by certain high-risk genotypes such as HPV-16, HPV-18 and closely related types, can progress to high grade dysplasias and carcinomas in women and men, including cervical, vulva, penile and anal cancers. A significant fraction of the head and neck cancers are also caused by HPV-16. The viral oncogenes responsible for neoplastic conversion are E6 and E7 that disrupt the pathways controlled by the two major tumor suppressor genes, p53 and members of pRB family. Because HPV cannot be propagated in conventional submerged monolayer cell cultures, organotypic epithelial raft cultures that generate a stratified and differentiated epithelium have been used to study the viral life cycle. This article describes several systems to examine aspects of the viral productive phase, along with the advantages and limitations. Animal model systems of HPV carcinogenesis are also briefly described.
    Keywords Papillomaviridae ; animal models ; carcinogenesis ; carcinoma ; cell culture ; epithelium ; genotype ; head ; humans ; men ; neck ; oncogenes ; tumor suppressor genes ; vulva ; women
    Language English
    Dates of publication 2015-04
    Size p. 92-100.
    Publishing place Springer-Verlag
    Document type Article
    ZDB-ID 2425817-9
    ISSN 1995-820X ; 1674-0769
    ISSN (online) 1995-820X
    ISSN 1674-0769
    DOI 10.1007/s12250-015-3600-9
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.

    Banerjee, N Sanjib / Moore, Dianne W / Broker, Thomas R / Chow, Louise T

    Proceedings of the National Academy of Sciences of the United States of America

    2018  Volume 115, Issue 47, Page(s) E11138–E11147

    Abstract: Human papillomaviruses (HPVs) cause epithelial proliferative diseases. Persistent infection of the mucosal epithelia by the high-risk genotypes can progress to high-grade dysplasia and cancers. Viral transcription and protein activities are intimately ... ...

    Abstract Human papillomaviruses (HPVs) cause epithelial proliferative diseases. Persistent infection of the mucosal epithelia by the high-risk genotypes can progress to high-grade dysplasia and cancers. Viral transcription and protein activities are intimately linked to regulation by histone acetyltransferases and histone deacetylases (HDACs) that remodel chromatin and regulate gene expression. HDACs are also essential to remodel and repair replicating chromatin to enable the progression of replication forks. As such, Vorinostat (suberoylanilide hydroximic acid), and other pan-HDAC inhibitors, are used to treat lymphomas. Here, we investigated the effects of Vorinostat on productive infection of the high-risk HPV-18 in organotypic cultures of primary human keratinocytes. HPV DNA amplifies in the postmitotic, differentiated cells of squamous epithelia, in which the viral oncoproteins E7 and E6 establish a permissive milieu by destabilizing major tumor suppressors, the pRB family proteins and p53, respectively. We showed that Vorinostat significantly reduced these E6 and E7 activities, abrogated viral DNA amplification, and inhibited host DNA replication. The E7-induced DNA damage response, which is critical for both events, was also compromised. Consequently, Vorinostat exposure led to DNA damage and triggered apoptosis in HPV-infected, differentiated cells, whereas uninfected tissues were spared. Apoptosis was attributed to highly elevated proapoptotic Bim isoforms that are known to be repressed by EZH2 in a repressor complex containing HDACs. Two other HDAC inhibitors, Belinostat and Panobinostat, also inhibited viral DNA amplification and cause apoptosis. We suggest that HDAC inhibitors are promising therapeutic agents to treat benign HPV infections, abrogate progeny virus production, and hence interrupt transmission.
    MeSH term(s) Apoptosis/drug effects ; Bcl-2-Like Protein 11/metabolism ; Cells, Cultured ; DNA Repair/drug effects ; DNA Replication/drug effects ; DNA, Viral/genetics ; DNA-Binding Proteins/metabolism ; Histone Deacetylase Inhibitors/pharmacology ; Histones/metabolism ; Human papillomavirus 18/drug effects ; Human papillomavirus 18/genetics ; Humans ; Hydroxamic Acids/pharmacology ; Keratinocytes/virology ; Mucous Membrane/virology ; Oncogene Proteins, Viral/metabolism ; Panobinostat/pharmacology ; Papillomavirus Infections/drug therapy ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/transmission ; Sulfonamides/pharmacology ; Tumor Suppressor Protein p53/metabolism ; Vorinostat/pharmacology
    Chemical Substances Bcl-2-Like Protein 11 ; DNA, Viral ; DNA-Binding Proteins ; E6 protein, Human papillomavirus type 18 ; E7 protein, Human papillomavirus type 18 ; H2AX protein, human ; Histone Deacetylase Inhibitors ; Histones ; Hydroxamic Acids ; Oncogene Proteins, Viral ; Sulfonamides ; Tumor Suppressor Protein p53 ; Vorinostat (58IFB293JI) ; Panobinostat (9647FM7Y3Z) ; belinostat (F4H96P17NZ)
    Language English
    Publishing date 2018-11-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1801156115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Human papillomavirus infections: warts or cancer?

    Chow, Louise T / Broker, Thomas R

    Cold Spring Harbor perspectives in biology

    2013  Volume 5, Issue 7

    Abstract: Human papillomaviruses (HPVs) are prevalent pathogens of mucosal and cutaneous epithelia. Productive infections of squamous epithelia lead to benign hyperproliferative warts, condylomata, or papillomas. Persistent infections of the anogenital mucosa by ... ...

    Abstract Human papillomaviruses (HPVs) are prevalent pathogens of mucosal and cutaneous epithelia. Productive infections of squamous epithelia lead to benign hyperproliferative warts, condylomata, or papillomas. Persistent infections of the anogenital mucosa by high-risk HPV genotypes 16 and 18 and closely related types can infrequently progress to high-grade intraepithelial neoplasias, carcinomas-in-situ, and invasive cancers in women and men. HPV-16 is also associated with a fraction of head and neck cancers. We discuss the interactions of the mucosotropic HPVs with the host regulatory proteins and pathways that lead to benign coexistence and enable HPV DNA amplification or, alternatively, to cancers that no longer support viral production.
    MeSH term(s) Alphapapillomavirus/genetics ; Alphapapillomavirus/physiology ; Female ; Genome, Viral ; Genotype ; Host-Pathogen Interactions ; Humans ; Male ; Papillomavirus Infections/genetics ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/virology ; Virus Replication ; Warts/genetics ; Warts/virology
    Language English
    Publishing date 2013-07-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ISSN 1943-0264
    ISSN (online) 1943-0264
    DOI 10.1101/cshperspect.a012997
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The male pachynema-specific protein MAPS drives phase separation in vitro and regulates sex body formation and chromatin behaviors in vivo.

    Lin, Zexiong / Li, Dongliang / Zheng, Jiahuan / Yao, Chencheng / Liu, Dongteng / Zhang, Hao / Feng, Haiwei / Chen, Chunxu / Li, Peng / Zhang, Yuxiang / Jiang, Binjie / Hu, Zhe / Zhao, Yu / Shi, Fu / Cao, Dandan / Rodriguez-Wallberg, Kenny A / Li, Zheng / Yeung, William S B / Chow, Louise T /
    Wang, Hengbin / Liu, Kui

    Cell reports

    2024  Volume 43, Issue 1, Page(s) 113651

    Abstract: Dynamic chromosome remodeling and nuclear compartmentalization take place during mammalian meiotic prophase I. We report here that the crucial roles of male pachynema-specific protein (MAPS) in pachynema progression might be mediated by its liquid-liquid ...

    Abstract Dynamic chromosome remodeling and nuclear compartmentalization take place during mammalian meiotic prophase I. We report here that the crucial roles of male pachynema-specific protein (MAPS) in pachynema progression might be mediated by its liquid-liquid phase separation in vitro and in cellulo. MAPS forms distinguishable liquid phases, and deletion or mutations of its N-terminal amino acids (aa) 2-9 disrupt its secondary structure and charge properties, impeding phase separation. Maps
    MeSH term(s) Humans ; Male ; Mice ; Animals ; Chromatin/metabolism ; Meiosis ; Pachytene Stage ; Phase Separation ; Meiotic Prophase I ; Spermatocytes/metabolism ; Mammals/genetics
    Chemical Substances Chromatin
    Language English
    Publishing date 2024-01-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2023.113651
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells.

    Srivastava, Ritesh K / Li, Changzhao / Khan, Jasim / Banerjee, Nilam Sanjib / Chow, Louise T / Athar, Mohammad

    Proceedings of the National Academy of Sciences of the United States of America

    2019  Volume 116, Issue 49, Page(s) 24583–24592

    Abstract: The mammalian target of rapamycin (mTOR) pathway, which plays a critical role in regulating cellular growth and metabolism, is aberrantly regulated in the pathogenesis of a variety of neoplasms. Here we demonstrate that dual mTORC1/mTORC2 inhibitors OSI- ... ...

    Abstract The mammalian target of rapamycin (mTOR) pathway, which plays a critical role in regulating cellular growth and metabolism, is aberrantly regulated in the pathogenesis of a variety of neoplasms. Here we demonstrate that dual mTORC1/mTORC2 inhibitors OSI-027 and PP242 cause catastrophic macropinocytosis in rhabdomyosarcoma (RMS) cells and cancers of the skin, breast, lung, and cervix, whereas the effects are much less pronounced in immortalized human keratinocytes. Using RMS as a model, we characterize in detail the mechanism of macropinocytosis induction. Macropinosomes are distinct from endocytic vesicles and autophagosomes in that they are single-membrane bound vacuoles formed by projection, ruffling, and contraction of plasma membranes. They are positive for EEA-1 and LAMP-1 and contain watery fluid but not organelles. The vacuoles then merge and rupture, killing the cells. We confirmed the inhibition of mTORC1/mTORC2 as the underpinning mechanism for macropinocytosis. Exposure to rapamycin, an mTORC1 inhibitor, or mTORC2 knockdown alone had little or reduced effect relative to the combination. We further demonstrate that macropinocytosis depends on MKK4 activated by elevated reactive oxygen species. In a murine xenograft model, OSI-027 reduced RMS tumor growth. Molecular characterization of the residual tumors was consistent with the induction of macropinocytosis. Furthermore, relative to the control xenograft tumors, the residual tumors manifested reduced expression of cell proliferation markers and proteins that drive the epithelial mesenchymal transition. These data indicate a role of mTORC2 in regulating tumor growth by macropinocytosis and suggest that dual inhibitors could help block refractory or recurrent RMS and perhaps other neoplasms and other cancer as well.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Cell Line, Tumor ; Cyclophosphamide/administration & dosage ; Epithelial-Mesenchymal Transition/drug effects ; Female ; Humans ; Imidazoles/administration & dosage ; Imidazoles/pharmacology ; Indoles/pharmacology ; MAP Kinase Kinase 4/metabolism ; Mechanistic Target of Rapamycin Complex 1/antagonists & inhibitors ; Mechanistic Target of Rapamycin Complex 2/antagonists & inhibitors ; Mice, Nude ; Pinocytosis/drug effects ; Purines/pharmacology ; Rhabdomyosarcoma/drug therapy ; Rhabdomyosarcoma/pathology ; Triazines/administration & dosage ; Triazines/pharmacology ; Vacuoles/drug effects ; Vacuoles/pathology ; Xenograft Model Antitumor Assays
    Chemical Substances Antineoplastic Agents ; Imidazoles ; Indoles ; OSI 027 ; Purines ; Triazines ; Cyclophosphamide (8N3DW7272P) ; Mechanistic Target of Rapamycin Complex 1 (EC 2.7.11.1) ; Mechanistic Target of Rapamycin Complex 2 (EC 2.7.11.1) ; MAP Kinase Kinase 4 (EC 2.7.12.2) ; MAP2K4 protein, human (EC 2.7.12.2) ; PP242 (H5669VNZ7V)
    Language English
    Publishing date 2019-11-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Video-Audio Media
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1911393116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Targeting DNA Damage Response as a Strategy to Treat HPV Infections.

    Banerjee, N Sanjib / Moore, Dianne / Parker, Cameron J / Broker, Thomas R / Chow, Louise T

    International journal of molecular sciences

    2019  Volume 20, Issue 21

    Abstract: Mucosotropic human papillomaviruses (HPVs) cause prevalent anogenital infections, some of which can progress to cancers. It is imperative to identify efficacious drug candidates, as there are few therapeutic options. We have recapitulated a robust ... ...

    Abstract Mucosotropic human papillomaviruses (HPVs) cause prevalent anogenital infections, some of which can progress to cancers. It is imperative to identify efficacious drug candidates, as there are few therapeutic options. We have recapitulated a robust productive program of HPV-18 in organotypic raft cultures of primary human keratinocytes. The HPV E7 protein induces S phase reentry, along with DNA damage response (DDR) in differentiated cells to support viral DNA amplification. A number of small molecule inhibitors of DDR regulators are in clinical use or clinical trials to treat cancers. Here, we used our raft culture system to examine effects of inhibitors of ATR/Chk1 and ATM/Chk2 on HPV infection. The inhibitors impaired S-phase reentry and progression as well as HPV DNA amplification. The Chk1 inhibitor MK-8776 was most effective, reducing viral DNA amplification by 90-99% and caused DNA damage and apoptosis, preferentially in HPV infected cells. We found that this sensitivity was imparted by the E7 protein and report that MK-8776 also caused extensive cell death of cervical cancer cell lines. Furthermore, it sensitized the cells to cisplatin, commonly used to treat advanced cervical cancer. Based on these observations, the Chk1 inhibitors could be potential effective agents to be re-purposed to treat the spectrum of HPV infections in single or combination therapy.
    MeSH term(s) Antineoplastic Agents/pharmacology ; Cell Death/drug effects ; Cell Line, Tumor ; Cells, Cultured ; Cisplatin/pharmacology ; DNA, Viral/antagonists & inhibitors ; DNA, Viral/genetics ; DNA, Viral/metabolism ; Female ; HeLa Cells ; Human papillomavirus 18/genetics ; Human papillomavirus 18/metabolism ; Human papillomavirus 18/physiology ; Humans ; Keratinocytes/drug effects ; Keratinocytes/metabolism ; Keratinocytes/virology ; Male ; Papillomavirus E7 Proteins/genetics ; Papillomavirus E7 Proteins/metabolism ; Papillomavirus Infections/genetics ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/virology ; Protein Kinase Inhibitors/pharmacology ; Pyrazoles/pharmacology ; Pyrimidines/pharmacology ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology ; Virus Replication/drug effects ; Virus Replication/genetics
    Chemical Substances Antineoplastic Agents ; DNA, Viral ; MK-8776 ; Papillomavirus E7 Proteins ; Protein Kinase Inhibitors ; Pyrazoles ; Pyrimidines ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2019-11-01
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms20215455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.

    Banerjee, N Sanjib / Moore, Dianne W / Wang, Hsu-Kun / Broker, Thomas R / Chow, Louise T

    Antiviral research

    2019  Volume 170, Page(s) 104559

    MeSH term(s) Antiviral Agents/pharmacology ; Cells, Cultured ; Clinical Trials, Phase II as Topic ; DNA Replication ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Foreskin/cytology ; Human papillomavirus 18/drug effects ; Human papillomavirus 18/genetics ; Human papillomavirus 18/physiology ; Humans ; Keratinocytes/drug effects ; Keratinocytes/virology ; Male ; Nitric Oxide/metabolism ; Oncogene Proteins, Viral/genetics ; Oncogene Proteins, Viral/metabolism ; Papillomavirus E7 Proteins/genetics ; Papillomavirus E7 Proteins/metabolism ; Siloxanes/pharmacology ; Virus Replication
    Chemical Substances Antiviral Agents ; DNA-Binding Proteins ; E6 protein, Human papillomavirus type 18 ; Oncogene Proteins, Viral ; Papillomavirus E7 Proteins ; Siloxanes ; Nitric Oxide (31C4KY9ESH) ; berdazimer sodium (ORT9SID4QY)
    Language English
    Publishing date 2019-07-15
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 306628-9
    ISSN 1872-9096 ; 0166-3542
    ISSN (online) 1872-9096
    ISSN 0166-3542
    DOI 10.1016/j.antiviral.2019.104559
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors.

    Wu, Shwu-Yuan / Lai, Hsien-Tsung / Sanjib Banerjee, N / Ma, Zonghui / Santana, Juan F / Wei, Shuguang / Liu, Xisheng / Zhang, Meirong / Zhan, Jian / Chen, Haiying / Posner, Bruce / Chen, Yadong / Price, David H / Chow, Louise T / Zhou, Jia / Chiang, Cheng-Ming

    Molecular cell

    2023  Volume 84, Issue 2, Page(s) 202–220.e15

    Abstract: Compounds binding to the bromodomains of bromodomain and extra-terminal (BET) family proteins, particularly BRD4, are promising anticancer agents. Nevertheless, side effects and drug resistance pose significant obstacles in BET-based therapeutics ... ...

    Abstract Compounds binding to the bromodomains of bromodomain and extra-terminal (BET) family proteins, particularly BRD4, are promising anticancer agents. Nevertheless, side effects and drug resistance pose significant obstacles in BET-based therapeutics development. Using high-throughput screening of a 200,000-compound library, we identified small molecules targeting a phosphorylated intrinsically disordered region (IDR) of BRD4 that inhibit phospho-BRD4 (pBRD4)-dependent human papillomavirus (HPV) genome replication in HPV-containing keratinocytes. Proteomic profiling identified two DNA damage response factors-53BP1 and BARD1-crucial for differentiation-associated HPV genome amplification. pBRD4-mediated recruitment of 53BP1 and BARD1 to the HPV origin of replication occurs in a spatiotemporal and BRD4 long (BRD4-L) and short (BRD4-S) isoform-specific manner. This recruitment is disrupted by phospho-IDR-targeting compounds with little perturbation of the global transcriptome and BRD4 chromatin landscape. The discovery of these protein-protein interaction inhibitors (PPIi) not only demonstrates the feasibility of developing PPIi against phospho-IDRs but also uncovers antiviral agents targeting an epigenetic regulator essential for virus-host interaction and cancer development.
    MeSH term(s) Humans ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Human Papillomavirus Viruses ; Papillomavirus Infections/drug therapy ; Papillomavirus Infections/genetics ; Proteomics ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Papillomaviridae/genetics ; Papillomaviridae/metabolism ; Viral Proteins/genetics ; Virus Replication/physiology ; DNA Repair ; Bromodomain Containing Proteins
    Chemical Substances Transcription Factors ; Nuclear Proteins ; Cell Cycle Proteins ; Viral Proteins ; BRD4 protein, human ; Bromodomain Containing Proteins
    Language English
    Publishing date 2023-12-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2023.11.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top